SCAMP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.607000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.661200E-01
Normal-vs-Stage2
7.118400E-01
Normal-vs-Stage3
6.846400E-01
Normal-vs-Stage4
8.744800E-01
Stage1-vs-Stage2
4.786200E-01
Stage1-vs-Stage3
2.198600E-01
Stage1-vs-Stage4
4.848600E-01
Stage2-vs-Stage3
2.633000E-01
Stage2-vs-Stage4
8.329800E-01
Stage3-vs-Stage4
6.138400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.886800E-01
Normal-vs-AfricanAmerican
7.316600E-01
Normal-vs-Asian
6.681000E-01
Caucasian-vs-AfricanAmerican
9.759000E-01
Caucasian-vs-Asian
6.178200E-01
AfricanAmerican-vs-Asian
7.926600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.685000E-01
Normal-vs-Female
7.754200E-01
Male-vs-Female
8.354600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.360600E-01
Normal-vs-Age(41-60Yrs)
5.926200E-01
Normal-vs-Age(61-80Yrs)
8.881000E-01
Normal-vs-Age(81-100Yrs)
4.928600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.246600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.987400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.425200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.515600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.141400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.553200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.536600E-01
Normal-vs-Daily Drinker
8.321400E-01
Normal-vs-Weekly Drinker
9.361600E-01
Normal-vs-Occasional Drinker
6.372800E-01
Normal-vs-Social Drinker
7.348200E-01
Non Drinker-vs-Daily Drinker
8.562200E-01
Non Drinker-vs-Weekly Drinker
6.663200E-01
Non Drinker-vs-Occasional Drinker
9.541400E-01
Non Drinker-vs-Social Drinker
2.714600E-01
Daily Drinker-vs-Weekly Drinker
8.046800E-01
Daily Drinker-vs-Occasional Drinker
8.838200E-01
Daily Drinker-vs-Social Drinker
3.912800E-01
Weekly Drinker-vs-Occasional Drinker
6.527000E-01
Weekly Drinker-vs-Social Drinker
5.584000E-01
Occasional Drinker-vs-Social Drinker
1.708160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.055600E-01
Normal-vs-Grade 2
1.610610E-01
Normal-vs-Grade 3
6.369600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.584790E-01
Grade 1-vs-Grade 3
2.529400E-01
Grade 1-vs-Grade 4
4.055600E-01
Grade 2-vs-Grade 3
8.217000E-01
Grade 2-vs-Grade 4
1.610610E-01
Grade 3-vs-Grade 4
6.369600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.930200E-01
Normal-vs-NonDiabetic
7.265200E-01
Diabetic-vs-NonDiabetic
1.317400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.749200E-01
Normal-vs-NoPancreatitis
8.540200E-01
Pancreatitis-vs-NoPancreatitis
9.593700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.984400E-01
Normal-vs-N1
7.195800E-01
N0-vs-N1
7.078200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.195200E-01
Normal-vs-TP53-NonMutant
7.308600E-01
TP53-Mutant-vs-TP53-NonMutant
1.591550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
